DCP MIDSTREAM, LP FORM 8-K. (Current report filing) Filed 04/13/12 for the Period Ending 04/09/12

Similar documents
WALGREEN CO. FORM 8-K (Unscheduled Material Events) Filed 6/5/2006 For Period Ending 6/5/2006

FORM8-K HILLENBRAND,INC.

FORM8-K HILLENBRAND,INC.

VICAL INC FORM 8-K. (Current report filing) Filed 11/02/06 for the Period Ending 11/02/06

HILLENBRAND INDUSTRIES INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

Inovio Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter)

Capital Senior Living Corporation

PIERIS PHARMACEUTICALS, INC. (Exact Name of Registrant as Specified in its Charter)

WALGREENS BOOTS ALLIANCE, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

VistaGen Therapeutics, Inc. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K CURRENT REPORT

HALOZYME THERAPEUTICS, INC. (Exact name of registrant as specified in its charter)

RULES OF CONDUCT OF INSIDERS RESPECTING

FORM 6-K. SECURITIES AND EXCHANGE COMMISSION Washington D.C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K CURRENT REPORT

Oragenics, Inc. (Exact name of registrant as specified in its charter)

RespireRx Pharmaceuticals Inc. Executives Presenting at the International Cannabinoid Derived Pharmaceuticals Summit

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K. ADVAXIS, INC. (Exact Name of Registrant as Specified in Charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K CURRENT REPORT

Titan Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

CONSTITUTION ARTICLE I NAME AND LOGO ARTICLE II OBJECTIVES AND PURPOSES ARTICLE III MEMBERSHIP

House Committee on Energy and Commerce House Committee on Energy and Commerce. Washington, DC Washington, DC 20515

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K. Neuralstem, Inc. (Exact name of registrant as specified in Charter)

VolitionRx Announces First Quarter 2016 Financial Results and Business Update

Chapter Affiliation Annual Report Workbook

AVEO Oncology Announces Strategic Restructuring. AVEO to Host Conference Call Wednesday, June 5 at 8:30 a.m. ET

TRAUMA RECOVERY/HAP OPERATING GUIDELINES

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update

-- Edasalonexent Substantially Slowed Duchenne Muscular Dystrophy Disease Progression through 36 Weeks --

DISCOVER THE BENEFITS OF MEMBERSHIP

Do not edit or delete any questions from this application. Doing so will result in immediate disqualification of your request.

AVEO and Astellas Announce Positive Findings from TIVO-1 Superiority Study of Tivozanib in First-Line Advanced RCC

CytoDyn Inc. (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

We are a network of successful REALTORS, advancing women as professionals and leaders in business, the industry and the communities we serve.

New Markets Tax Credit CDE Certification Question & Answer

Memory Pharmaceuticals Establishes Plans for Clinical Program for MEM 3454 in Schizophrenia. -Broadens Roche Nicotinic Alpha-7 Alliance-

Corporate Membership Application

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C Form 6-K

Report to the GAVI Alliance Board 7-8 July 2011

STATE OF NEW JERSEY DEPARTMENT OF CORRECTIONS. Medication Assisted Treatment For Substance Use Disorder In the New Jersey County Jails

GENERAL INFORMATION AND INSTRUCTIONS

2006 Annual Report. Anastomosis Made Simple

National Association of the Deaf NAD BOARD OF DIRECTORS MEETING Freemont, California October 12, 2012

2017 District 44 Mid-Year TLI

FEDERAL NATIONAL MORTGAGE ASSOCIATION FANNIE MAE

PIERIS PHARMACEUTICALS, INC. (Exact Name of Registrant as Specified in its Charter)

2017 District 44 Summer TLI

A NIGHT WITH THE STARS SPONSORSHIP PACKET

Titan Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter)

MDCH IRB REVIEW APPLICATION Authority: Code of Federal Regulations Title 45 Part 46

Standards of Conduct for Transmission Providers

Broad and clinically important benefits beyond the initial registrational endpoints are now reported.

AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15.

Business Partner Program WELCOME Thank you for your interest and support of the Denver legal community!

Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia

RESOLUTION NO A RESOLUTION APPROVING REFERAL TO THE ELECTORS OF THE CITY OF ALBANY THE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

DELTA DENTAL PREMIER

ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update

Avenue Therapeutics, Inc. August 2016

ABSOLUTE NNN LEASE 19 Years Remaining 8815 Stagecoach Rd. Little Rock, AR 72210

Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019

YOUR RESPONSIBILITIES

34 th Annual J.P. Morgan Healthcare Conference

OVERSEAS SCHOOL OF COLOMBO SCHOOL COMMUNITY NETWORK (SCN) CONSTITUTION

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology

ORDER OF THE LIEUTENANT GOVERNOR IN COUNCIL

BVI Limited Partnership Hedge Funds: Calling Japan

DIAL/SELF Youth and Community Services YouthServe AmeriCorps Program

Integrity Applications, Inc. (Exact Name of Registrant as Specified in Its Charter)

INFINITY PHARMACEUTICALS, INC.

Annual Shareholders Meeting

Aviragen Therapeutics, Inc. and Vaxart Inc. Joint Conference Call UNLOCKING THE FULL POTENTIAL OF ORAL VACCINES

INVESTOR PRESENTATION

SUNDAY, MARCH 24 TUESDAY, MARCH 26, 2019 THE MAYFLOWER HOTEL, WASHINGTON, DC 20 Y E A R S CELEBRATING 20 YEARS OF QUALITY

Cancer Support Scotland AGM & Speakers Morning

Regulatory Framework for Medical Devices in South Africa. 23 November 2018 Andrea Keyter Deputy Director: Medical Devices

Ministry of Health and Long-Term Care. Palliative Care. Follow-Up on VFM Section 3.08, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW

Sponsor. Exhibitor Information. Colorado NARO Board of Directors. Rob Prentice President. James Elder Vice President

City of Carson 701 E. Carson St., Carson, CA Telephone: (310) ; ci.carson.ca.us

For personal use only

The Health Innovation Partnership. Scott Johnstone Scottish Lifesciences Association

Business Partner Program WELCOME. Thank you for your interest and support of the Denver legal community!

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

Satellite Club or New Club The Right Fit

Theravance Announces Positive Results from Phase 1 and Phase 2 Clinical Studies with TD-1211 in Development for Opioid-Induced Constipation

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS

Annex 1. CHOONG YEE HOW List of past directorships. 1. Hong Leong Islamic Bank Berhad. 2. Promilia Berhad. 3. HL Asset Management Pte Ltd

ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update

Corporate Presentation

For personal use only

The Dental Corporation Opportunity

Business Partner Program WELCOME. Thank you for your interest and support of the Denver legal community!

Transcription:

DCP MIDSTREAM, LP FORM 8-K (Current report filing) Filed 04/13/12 for the Period Ending 04/09/12 Address 370 17TH STREET SUITE 2500 DENVER, CO, 80202 Telephone 303-595-3331 CIK 0001338065 Symbol DCP SIC Code 4922 - Natural Gas Transmission Industry Oil & Gas Transportation Services Sector Energy Fiscal Year 12/31 http://www.edgar-online.com Copyright 2018, EDGAR Online, a division of Donnelley Financial Solutions. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, a division of Donnelley Financial Solutions, Terms of Use.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): April 9, 2012 DCP MIDSTREAM PARTNERS, LP (Exact name of registrant as specified in its charter) Delaware 001-32678 03-0567133 (State or other jurisdiction of incorporation) (Commission File No.) (IRS Employer Identification No.) 370 17th Street, Suite 2775 Denver, Colorado 80202 (Address of principal executive offices) (Zip Code) (303) 633-2900 (Registrant s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 12, 2012, DCP Midstream Partners, LP (the Partnership ) issued a press release, announcing that Angela A. Minas, Vice President and Chief Financial Officer of DCP Midstream GP, LLC ( DCP Midstream GP ), the Partnership s general partner, has decided to leave the Partnership effective May 11, 2012 to pursue other interests, and that Rose M. Robeson was appointed Senior Vice President and Chief Financial Officer of DCP Midstream GP, also effective May 11, 2012. Ms. Robeson, age 51, is currently the Group Vice President, Chief Financial Officer of DCP Midstream, LLC, the owner of DCP Midstream GP, and has served in that position since 2002. Prior to that time she was Vice President, Treasurer of DCP Midstream, LLC from 2000 to 2002. Prior to joining DCP Midstream, LLC, Ms. Robeson was with Kinder Morgan (formerly KN Energy) from 1996 to 2000, where she served as Vice President and Treasurer from 1998 to 2000. Prior that time she served in a number of finance positions at Total Petroleum from 1987 to 1996. She began her career as a certified public accountant with Ernst & Young. Ms. Robeson has nearly 30 years of experience in finance and 25 years of experience in the energy industry. Ms. Robeson will receive an annual base salary of $293,000 in her new position. In addition, she will participate in the Partnership s short term cash incentive program with a target incentive opportunity of 50% of her base salary, pro-rated for 2012 based on the percentage of the year she works for the Partnership. Ms. Robeson will participate in the DCP Midstream, LLC long term incentive plan for 2012 and is then expected to participate in the Partnership s long term incentive plan for 2013. The press release announcing Ms. Minas departure and the appointment of Ms. Robeson is attached hereto as Exhibit 99.1. The information in Exhibit 99.1 is being furnished pursuant to this Item 5.02. Item 9.01 Financial Statements and Exhibits. (d) Exhibit No. Exhibits. Description 99.1 Press Release dated April 12, 2012.

SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: April 13, 2012 DCP MIDSTREAM PARTNERS, LP By: DCP MIDSTREAM GP, LP, its General Partner By: DCP MIDSTREAM GP, LLC, its General Partner By: /s/ Michael S. Richards Name: Michael S. Richards Title: Vice President, General Counsel, and Secretary

EXHIBIT INDEX Exhibit No. Description 99.1 Press Release dated April 12, 2012.

Exhibit 99.1 April 12, 2012 DCP Midstream Partners CONTACT: DCP Midstream CONTACT: News Release 370 17 th Street, Suite 2500 Denver, CO 80202 www.dcppartners.com www.dcpmidstream.com Jonni Anwar 303-605-1868 Lisa Newkirk 303-605-1837 303-829-1953 DCP MIDSTREAM PARTNERS, LP AND DCP MIDSTREAM, LLC ANNOUNCE MANAGEMENT CHANGES DENVER, April 12, 2012 DCP Midstream Partners, LP (NYSE: DPM) (the Partnership) and DCP Midstream, LLC (DCP Midstream), the owner of the general partner of the Partnership, announced today that effective May 11, 2012, Angela A. Minas, the Partnership s vice president and CFO, has decided to leave the Partnership to pursue other interests and Rose M. Robeson, currently group vice president and CFO of DCP Midstream, will be appointed to the position of senior vice president and CFO of the Partnership. In conjunction with this move and as part of periodic rotational management changes within the overall DCP enterprise, Sean O Brien, currently vice president financial planning and analysis and treasurer of DCP Midstream, will be appointed to the position of senior vice president and CFO of DCP Midstream. O Brien joined DCP Midstream in 2009 from Duke Energy, where O Brien served in several senior financial leadership positions. In addition, Scott Delmoro, who is currently in a developmental role in the commercial organization, will become vice president and treasurer of DCP Midstream. Delmoro also previously served as the vice president and controller of DCP Midstream. We would like to thank Angela for her significant contributions to the Partnership s successful execution of its growth strategy. During Angela s three years with the Partnership she performed a crucial role in the design and execution of our financing plan and positioning the Partnership for success. We are also very pleased to have Rose, who has overseen DCP Midstream s overall financial plans and relationships with its investors and commercial banks, rotate within the DCP enterprise to provide a seamless transition to the role of senior vice president and CFO of the Partnership. Rose brings a wealth of experience to the Partnership having over 25 years of industry experience, most recently as the group vice president and CFO of DCP Midstream for the past 10 years, said Mark Borer, president and CEO of the Partnership. Robeson also previously served in leadership positions at Total Petroleum and Kinder Morgan (formerly KN Energy). About DCP Midstream Partners, LP DCP Midstream Partners, LP (NYSE: DPM) is a midstream master limited partnership engaged in the business of gathering, compressing, treating, processing, transporting, storing and selling natural

gas; producing, fractionating, transporting, storing and selling NGLs and condensate; and transporting, storing and selling propane in wholesale markets. DCP Midstream Partners, LP is managed by its general partner, DCP Midstream GP, LLC, which is wholly owned by DCP Midstream, LLC, a joint venture between Spectra Energy and ConocoPhillips. For more information, visit the DCP Midstream Partners, LP website at http://www.dcppartners.com. About DCP Midstream, LLC DCP Midstream, LLC with headquarters in Denver, leads the midstream segment as the second-largest natural gas gatherer and processor, the largest natural gas liquids producer and one of the largest marketers in the United States. DCP Midstream operates in 18 states across major producing regions. DCP Midstream is a 50:50 joint venture between Spectra Energy and ConocoPhillips. The company owns the general partner of DCP Midstream Partners LP, a master limited partnership, and provides operational and administrative support to the partnership. DCP Midstream is the largest oil and gas company, the largest private company and one of the Best Places to Work in Denver as ranked by the Denver Business Journal. For more information, visit the DCP Midstream website at www.dcpmidstream.com. ### -2-